Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
70 hedge funds and large institutions have $251M invested in Applied Therapeutics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 7 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
1% more funds holding
Funds holding: 69 → 70 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.21% less ownership
Funds ownership: 58.93% → 57.71% (-1.2%)
20% less call options, than puts
Call options by funds: $1.29M | Put options by funds: $1.62M
21% less capital invested
Capital invested by funds: $319M → $251M (-$68.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.03M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$596K |
| 3 |
State Street
Boston,
Massachusetts
|
+$507K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$435K |
| 5 |
Two Sigma Investments
New York
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alkeon Capital Management
New York
|
-$6.94M |
| 2 |
BAMCO Inc
New York
|
-$4.94M |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$2.75M |
| 4 |
DP
DSAM Partners
London,
United Kingdom
|
-$1.4M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$545K |
APLT Hedge Fund Activity: Q3 2021 in Review
70 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2021, worth a combined $251M — down 21% from $319M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new APLT positions and 7 closed out — a net gain of 1 holder — while 21 added to existing stakes and 18 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $9.03M. The largest seller was Alkeon Capital Management, cutting an estimated $6.94M.
- 70 institutional investors held Applied Therapeutics (APLT) as of Q3 2021, up from 69 in Q2 2021.
- Funds reported $251M of Applied Therapeutics stock for Q3 2021, down 21% quarter-over-quarter.
- 8 funds opened new Applied Therapeutics positions in Q3 2021 and 7 closed out, a net change of +1 holder.
- The largest Applied Therapeutics buyer in Q3 2021 was Point72 Asset Management, an estimated $9.03M added.
- The largest Applied Therapeutics seller in Q3 2021 was Alkeon Capital Management, an estimated $6.94M sold.
Based on aggregated 13F filings for Q3 2021.